

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.26086728 |
| 2 | proteasome assembly (GO:0043248) | 5.22294941 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.84259990 |
| 4 | response to peptidoglycan (GO:0032494) | 4.60594729 |
| 5 | cellular extravasation (GO:0045123) | 4.53681563 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.52255237 |
| 7 | detection of molecule of bacterial origin (GO:0032490) | 4.37910350 |
| 8 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.31314574 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.27719227 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.27719227 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.27719227 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.27719227 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.27719227 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.27719227 |
| 15 | ribosome assembly (GO:0042255) | 4.26200635 |
| 16 | ribosomal small subunit biogenesis (GO:0042274) | 4.22988622 |
| 17 | amino sugar catabolic process (GO:0046348) | 4.21311608 |
| 18 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.12293805 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.08992065 |
| 20 | termination of RNA polymerase III transcription (GO:0006386) | 4.08992065 |
| 21 | GMP metabolic process (GO:0046037) | 4.02422308 |
| 22 | maturation of SSU-rRNA (GO:0030490) | 4.00905821 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.80669945 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.77062737 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75189075 |
| 26 | ribosomal large subunit biogenesis (GO:0042273) | 3.71692716 |
| 27 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.70988663 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.69239740 |
| 29 | hepatocyte apoptotic process (GO:0097284) | 3.59496755 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.58024726 |
| 31 | DNA replication initiation (GO:0006270) | 3.51092131 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51064813 |
| 33 | detection of other organism (GO:0098543) | 3.50896797 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.50588811 |
| 35 | hypotonic response (GO:0006971) | 3.49156277 |
| 36 | DNA replication checkpoint (GO:0000076) | 3.44424982 |
| 37 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.43962273 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.43893314 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.41928273 |
| 40 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.40880116 |
| 41 | macrophage activation (GO:0042116) | 3.40731792 |
| 42 | embryonic process involved in female pregnancy (GO:0060136) | 3.38809579 |
| 43 | telomere maintenance via recombination (GO:0000722) | 3.36444643 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36008213 |
| 45 | viral transcription (GO:0019083) | 3.34765275 |
| 46 | pseudouridine synthesis (GO:0001522) | 3.34131983 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33745677 |
| 48 | histone H3-K36 demethylation (GO:0070544) | 3.29828773 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.27784941 |
| 50 | negative regulation of cell killing (GO:0031342) | 3.26788488 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.26788488 |
| 52 | N-acetylneuraminate metabolic process (GO:0006054) | 3.25629994 |
| 53 | regulation of leukocyte degranulation (GO:0043300) | 3.25435948 |
| 54 | ribosomal small subunit assembly (GO:0000028) | 3.24213801 |
| 55 | neutrophil activation (GO:0042119) | 3.24164642 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22765752 |
| 57 | rRNA processing (GO:0006364) | 3.22716434 |
| 58 | translational termination (GO:0006415) | 3.21280444 |
| 59 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.19831583 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17828026 |
| 61 | response to host immune response (GO:0052572) | 3.17828026 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.14207023 |
| 63 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.14176675 |
| 64 | microglial cell activation (GO:0001774) | 3.11612378 |
| 65 | megakaryocyte development (GO:0035855) | 3.11039762 |
| 66 | granulocyte activation (GO:0036230) | 3.11029801 |
| 67 | neutrophil mediated immunity (GO:0002446) | 3.11004519 |
| 68 | rRNA metabolic process (GO:0016072) | 3.10944229 |
| 69 | termination of RNA polymerase I transcription (GO:0006363) | 3.10766141 |
| 70 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.09453289 |
| 71 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.09349916 |
| 72 | regulation of mast cell activation (GO:0033003) | 3.09086906 |
| 73 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.08993269 |
| 74 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08368852 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08105042 |
| 76 | response to folic acid (GO:0051593) | 3.07349008 |
| 77 | detection of biotic stimulus (GO:0009595) | 3.07311525 |
| 78 | rRNA modification (GO:0000154) | 3.07245221 |
| 79 | regulation of histone H3-K27 methylation (GO:0061085) | 3.06958734 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.06648686 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05957737 |
| 82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05844456 |
| 83 | response to host (GO:0075136) | 3.05844456 |
| 84 | response to host defenses (GO:0052200) | 3.05844456 |
| 85 | ribosome biogenesis (GO:0042254) | 3.00837711 |
| 86 | purine nucleobase biosynthetic process (GO:0009113) | 3.00436484 |
| 87 | respiratory chain complex IV assembly (GO:0008535) | 3.00073331 |
| 88 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99487840 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99468690 |
| 90 | tRNA methylation (GO:0030488) | 2.99099554 |
| 91 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.98706697 |
| 92 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.97857441 |
| 93 | cellular response to ethanol (GO:0071361) | 2.93416129 |
| 94 | kinetochore assembly (GO:0051382) | 2.92031004 |
| 95 | transcription from RNA polymerase I promoter (GO:0006360) | 2.91232591 |
| 96 | germinal center formation (GO:0002467) | 2.90338290 |
| 97 | DNA strand elongation (GO:0022616) | 2.89247708 |
| 98 | nuclear pore complex assembly (GO:0051292) | 2.89201188 |
| 99 | detection of bacterium (GO:0016045) | 2.89192005 |
| 100 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.88987098 |
| 101 | mitotic recombination (GO:0006312) | 2.87905813 |
| 102 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.87252145 |
| 103 | nucleobase biosynthetic process (GO:0046112) | 2.86209829 |
| 104 | telomere maintenance via telomere lengthening (GO:0010833) | 2.84454359 |
| 105 | positive regulation of mast cell degranulation (GO:0043306) | 2.84278936 |
| 106 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.84278936 |
| 107 | protein heterotetramerization (GO:0051290) | 2.83377734 |
| 108 | cotranslational protein targeting to membrane (GO:0006613) | 2.83020461 |
| 109 | tRNA modification (GO:0006400) | 2.82447278 |
| 110 | 7-methylguanosine mRNA capping (GO:0006370) | 2.81266561 |
| 111 | definitive hemopoiesis (GO:0060216) | 2.81234344 |
| 112 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.81138678 |
| 113 | regulation of macrophage cytokine production (GO:0010935) | 2.79983294 |
| 114 | protein targeting to ER (GO:0045047) | 2.79891878 |
| 115 | lymphoid progenitor cell differentiation (GO:0002320) | 2.78874817 |
| 116 | 7-methylguanosine RNA capping (GO:0009452) | 2.78461352 |
| 117 | RNA capping (GO:0036260) | 2.78461352 |
| 118 | negative regulation of metanephros development (GO:0072217) | 2.78303028 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78294250 |
| 120 | GDP-mannose metabolic process (GO:0019673) | 2.77880541 |
| 121 | respiratory burst (GO:0045730) | 2.76672759 |
| 122 | translational initiation (GO:0006413) | 2.75682434 |
| 123 | maturation of 5.8S rRNA (GO:0000460) | 2.73731485 |
| 124 | pinocytosis (GO:0006907) | 2.73367890 |
| 125 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.72775387 |
| 126 | sphingoid metabolic process (GO:0046519) | 2.72508854 |
| 127 | mature B cell differentiation (GO:0002335) | 2.71131555 |
| 128 | iron ion import (GO:0097286) | 2.70693519 |
| 129 | DNA ligation (GO:0006266) | 2.70583525 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.68948471 |
| 131 | protein localization to endoplasmic reticulum (GO:0070972) | 2.68530899 |
| 132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.67236636 |
| 133 | positive regulation of interferon-alpha production (GO:0032727) | 2.67166041 |
| 134 | response to laminar fluid shear stress (GO:0034616) | 2.66489907 |
| 135 | positive regulation of B cell differentiation (GO:0045579) | 2.65992784 |
| 136 | positive regulation of granulocyte differentiation (GO:0030854) | 2.65881683 |
| 137 | RNA methylation (GO:0001510) | 2.65783894 |
| 138 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.65710098 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.65473197 |
| 140 | cellular component biogenesis (GO:0044085) | 2.65227683 |
| 141 | T cell migration (GO:0072678) | 2.63720587 |
| 142 | GPI anchor biosynthetic process (GO:0006506) | 2.63515885 |
| 143 | protein K6-linked ubiquitination (GO:0085020) | 2.63492947 |
| 144 | DNA damage response, detection of DNA damage (GO:0042769) | 2.63175430 |
| 145 | DNA-dependent DNA replication (GO:0006261) | 2.63135963 |
| 146 | keratinocyte development (GO:0003334) | 2.62587162 |
| 147 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62180159 |
| 148 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61769651 |
| 149 | oligosaccharide catabolic process (GO:0009313) | 2.61442573 |
| 150 | regulation of pigment cell differentiation (GO:0050932) | 2.60988826 |
| 151 | negative thymic T cell selection (GO:0045060) | 2.60957935 |
| 152 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.60590607 |
| 153 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60485415 |
| 154 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.60016616 |
| 155 | negative regulation of interleukin-17 production (GO:0032700) | 2.59949188 |
| 156 | superoxide anion generation (GO:0042554) | 2.59706979 |
| 157 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.58908234 |
| 158 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.58585513 |
| 159 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58298668 |
| 160 | regulation of regulated secretory pathway (GO:1903305) | 2.57853082 |
| 161 | DNA integration (GO:0015074) | 2.57597097 |
| 162 | spliceosomal snRNP assembly (GO:0000387) | 2.56643021 |
| 163 | regulation of necroptotic process (GO:0060544) | 2.56065895 |
| 164 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.54965138 |
| 165 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54469078 |
| 166 | myeloid cell development (GO:0061515) | 2.54374529 |
| 167 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.52956601 |
| 168 | facial nerve structural organization (GO:0021612) | 2.52330938 |
| 169 | negative regulation of T cell mediated immunity (GO:0002710) | 2.51947247 |
| 170 | immunoglobulin mediated immune response (GO:0016064) | 2.51791823 |
| 171 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.51447531 |
| 172 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51293614 |
| 173 | leukocyte degranulation (GO:0043299) | 2.50848087 |
| 174 | centriole assembly (GO:0098534) | 2.49458498 |
| 175 | kinetochore organization (GO:0051383) | 2.48966543 |
| 176 | C-terminal protein lipidation (GO:0006501) | 2.48606494 |
| 177 | negative T cell selection (GO:0043383) | 2.48397176 |
| 178 | vitamin transmembrane transport (GO:0035461) | 2.48019554 |
| 179 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.47963422 |
| 180 | leukocyte aggregation (GO:0070486) | 2.47937215 |
| 181 | regulation of interferon-alpha production (GO:0032647) | 2.47933556 |
| 182 | cytochrome complex assembly (GO:0017004) | 2.47474796 |
| 183 | postsynaptic membrane organization (GO:0001941) | 2.47444397 |
| 184 | dosage compensation (GO:0007549) | 2.47428091 |
| 185 | translational elongation (GO:0006414) | 2.45843357 |
| 186 | mesonephros development (GO:0001823) | 2.45828268 |
| 187 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.45822951 |
| 188 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.45429356 |
| 189 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.44650469 |
| 190 | myeloid leukocyte activation (GO:0002274) | 2.44568452 |
| 191 | DNA-templated transcription, elongation (GO:0006354) | 2.43944986 |
| 192 | translation (GO:0006412) | 2.43190376 |
| 193 | ncRNA processing (GO:0034470) | 2.43019802 |
| 194 | mannosylation (GO:0097502) | 2.42490526 |
| 195 | endothelium development (GO:0003158) | 2.40561824 |
| 196 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.39531289 |
| 197 | cellular protein complex disassembly (GO:0043624) | 2.39503288 |
| 198 | RNA modification (GO:0009451) | 2.39418052 |
| 199 | mitochondrion degradation (GO:0000422) | 2.38904179 |
| 200 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.38607371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.21373722 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.80465676 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.51663826 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.02368022 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.73569769 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.54145173 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.45478180 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.42456332 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.35533866 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.32372397 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.21117848 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.17843772 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13979830 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.11849168 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.02516034 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.85264511 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.75358146 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75290053 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.73979389 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.68166900 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67589416 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.67116560 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.62789274 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.55658651 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.52981829 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.46369747 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38016249 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32726945 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.31866823 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.25883171 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20558877 |
| 32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.18543825 |
| 33 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.16845624 |
| 34 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15256079 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11166006 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.11053808 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.10230018 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.08044386 |
| 39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.07149547 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 2.06399422 |
| 41 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.05970149 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.05588227 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00873781 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00163276 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99480582 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.99085749 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.98428445 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98206452 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97564332 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97559449 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.96646316 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.95676810 |
| 53 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.92783263 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.91639224 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.90922565 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88966527 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.87480597 |
| 58 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.82214270 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77581380 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.77429619 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.70323114 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68723417 |
| 63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66205190 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63518603 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.61176643 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.58610335 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.58189616 |
| 68 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.56891608 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56602867 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56313471 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55928978 |
| 72 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.55469786 |
| 73 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.55469786 |
| 74 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.55469786 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55233026 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55102024 |
| 77 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53120742 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52958605 |
| 79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.52394184 |
| 80 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.52331898 |
| 81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51174951 |
| 82 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.50476974 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49810008 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49748363 |
| 85 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49398289 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48127809 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46289693 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45719574 |
| 89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44713084 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44592019 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43301788 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42835673 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40004959 |
| 94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39111110 |
| 95 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38651085 |
| 96 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38332322 |
| 97 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37908950 |
| 98 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.37676638 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37112790 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36805584 |
| 101 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33862691 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33821816 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32652718 |
| 104 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29174684 |
| 105 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.29114616 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28168462 |
| 107 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28081207 |
| 108 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27531356 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26250497 |
| 110 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25244919 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24376689 |
| 112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24147651 |
| 113 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23769643 |
| 114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23644585 |
| 115 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.21802597 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21770758 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21384764 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21384764 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20567813 |
| 120 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19922664 |
| 121 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18001692 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17188211 |
| 123 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15863774 |
| 124 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14515423 |
| 125 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14159350 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 1.13842022 |
| 127 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13174550 |
| 128 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12777089 |
| 129 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12077154 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12056945 |
| 131 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.09501389 |
| 132 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07603619 |
| 133 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07261664 |
| 134 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07006313 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06678796 |
| 136 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05879616 |
| 137 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04292857 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03417206 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01975665 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01239681 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00863110 |
| 142 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00217002 |
| 143 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99247742 |
| 144 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98977953 |
| 145 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96587231 |
| 146 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96249521 |
| 147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95483687 |
| 148 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94777896 |
| 149 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93915864 |
| 150 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93367145 |
| 151 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90696577 |
| 152 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.90472323 |
| 153 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89878545 |
| 154 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.89335162 |
| 155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89279778 |
| 156 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88843181 |
| 157 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88516669 |
| 158 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.87845456 |
| 159 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86741629 |
| 160 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86656818 |
| 161 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86450520 |
| 162 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86442999 |
| 163 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86283603 |
| 164 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86090041 |
| 165 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84756218 |
| 166 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84018674 |
| 167 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82861416 |
| 168 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82567223 |
| 169 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.82504291 |
| 170 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.80557130 |
| 171 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.78069317 |
| 172 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78064165 |
| 173 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76634713 |
| 174 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.75185566 |
| 175 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.74283393 |
| 176 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72566989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.92964841 |
| 2 | MP0001188_hyperpigmentation | 3.79086320 |
| 3 | MP0005409_darkened_coat_color | 3.59079782 |
| 4 | MP0004381_abnormal_hair_follicle | 3.58830624 |
| 5 | MP0009379_abnormal_foot_pigmentation | 3.57388014 |
| 6 | MP0008260_abnormal_autophagy | 3.47661622 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.29386875 |
| 8 | MP0006292_abnormal_olfactory_placode | 3.27629971 |
| 9 | MP0000015_abnormal_ear_pigmentation | 2.92110213 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.89684141 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.72554712 |
| 12 | MP0003718_maternal_effect | 2.50244465 |
| 13 | MP0003724_increased_susceptibility_to | 2.44064071 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.41706234 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.39535989 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.30577993 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.24876456 |
| 18 | MP0003111_abnormal_nucleus_morphology | 2.12093751 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.08881797 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.08070519 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.06602741 |
| 22 | MP0008057_abnormal_DNA_replication | 2.03472526 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.03432923 |
| 24 | MP0008058_abnormal_DNA_repair | 1.98591703 |
| 25 | MP0004947_skin_inflammation | 1.95990132 |
| 26 | MP0010094_abnormal_chromosome_stability | 1.94229182 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.89763422 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.88857985 |
| 29 | MP0003786_premature_aging | 1.86886387 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.78800768 |
| 31 | MP0005671_abnormal_response_to | 1.71865588 |
| 32 | MP0003938_abnormal_ear_development | 1.70494758 |
| 33 | MP0000490_abnormal_crypts_of | 1.70076488 |
| 34 | MP0003091_abnormal_cell_migration | 1.68038184 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.66292567 |
| 36 | MP0002102_abnormal_ear_morphology | 1.63764867 |
| 37 | MP0002095_abnormal_skin_pigmentation | 1.63660177 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.59270618 |
| 39 | MP0009278_abnormal_bone_marrow | 1.56975629 |
| 40 | MP0003941_abnormal_skin_development | 1.55687848 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.54923795 |
| 42 | MP0003077_abnormal_cell_cycle | 1.54566379 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.52237136 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.51943994 |
| 45 | MP0005451_abnormal_body_composition | 1.51025716 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.50928476 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.50565925 |
| 48 | MP0006082_CNS_inflammation | 1.49722109 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.49048342 |
| 50 | MP0002009_preneoplasia | 1.47853894 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.47590031 |
| 52 | MP0003315_abnormal_perineum_morphology | 1.45770297 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.44299630 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.42281022 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.41172751 |
| 56 | MP0009785_altered_susceptibility_to | 1.34808335 |
| 57 | MP0009840_abnormal_foam_cell | 1.32254329 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.28362624 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.27969869 |
| 60 | MP0002132_abnormal_respiratory_system | 1.27759620 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.27235873 |
| 62 | MP0003878_abnormal_ear_physiology | 1.27235873 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.27122109 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.26486600 |
| 65 | MP0005025_abnormal_response_to | 1.26295382 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.24733314 |
| 67 | MP0003303_peritoneal_inflammation | 1.22259901 |
| 68 | MP0003880_abnormal_central_pattern | 1.21666771 |
| 69 | MP0008932_abnormal_embryonic_tissue | 1.20561222 |
| 70 | MP0005310_abnormal_salivary_gland | 1.19415410 |
| 71 | MP0009764_decreased_sensitivity_to | 1.19320334 |
| 72 | MP0002723_abnormal_immune_serum | 1.16597733 |
| 73 | MP0004510_myositis | 1.16397193 |
| 74 | MP0002163_abnormal_gland_morphology | 1.16293601 |
| 75 | MP0001851_eye_inflammation | 1.15297770 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14967400 |
| 77 | MP0002177_abnormal_outer_ear | 1.13983330 |
| 78 | MP0002419_abnormal_innate_immunity | 1.13381144 |
| 79 | MP0000681_abnormal_thyroid_gland | 1.12845269 |
| 80 | MP0008007_abnormal_cellular_replicative | 1.11002037 |
| 81 | MP0002420_abnormal_adaptive_immunity | 1.10198161 |
| 82 | MP0001819_abnormal_immune_cell | 1.10137597 |
| 83 | MP0004883_abnormal_blood_vessel | 1.09187682 |
| 84 | MP0008004_abnormal_stomach_pH | 1.08489752 |
| 85 | MP0000566_synostosis | 1.07882995 |
| 86 | MP0004233_abnormal_muscle_weight | 1.07427003 |
| 87 | MP0005621_abnormal_cell_physiology | 1.07151493 |
| 88 | MP0002452_abnormal_antigen_presenting | 1.06971356 |
| 89 | MP0001800_abnormal_humoral_immune | 1.06799823 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 1.04282807 |
| 91 | MP0003436_decreased_susceptibility_to | 1.03536725 |
| 92 | MP0003828_pulmonary_edema | 1.02300643 |
| 93 | MP0005164_abnormal_response_to | 1.01203523 |
| 94 | MP0002638_abnormal_pupillary_reflex | 1.00088501 |
| 95 | MP0002160_abnormal_reproductive_system | 0.99922129 |
| 96 | MP0003448_altered_tumor_morphology | 0.98209437 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.97405725 |
| 98 | MP0002398_abnormal_bone_marrow | 0.96510379 |
| 99 | MP0000604_amyloidosis | 0.95906285 |
| 100 | MP0000716_abnormal_immune_system | 0.95793830 |
| 101 | MP0001915_intracranial_hemorrhage | 0.95725398 |
| 102 | MP0008469_abnormal_protein_level | 0.94968177 |
| 103 | MP0001661_extended_life_span | 0.94466495 |
| 104 | MP0001853_heart_inflammation | 0.92725224 |
| 105 | MP0000689_abnormal_spleen_morphology | 0.92626036 |
| 106 | MP0008995_early_reproductive_senescence | 0.92223637 |
| 107 | MP0002722_abnormal_immune_system | 0.92074748 |
| 108 | MP0001919_abnormal_reproductive_system | 0.91820686 |
| 109 | MP0002751_abnormal_autonomic_nervous | 0.91495220 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.90854306 |
| 111 | MP0005083_abnormal_biliary_tract | 0.90074880 |
| 112 | MP0000613_abnormal_salivary_gland | 0.89819416 |
| 113 | MP0003690_abnormal_glial_cell | 0.89268912 |
| 114 | MP0003075_altered_response_to | 0.89197779 |
| 115 | MP0000049_abnormal_middle_ear | 0.88688583 |
| 116 | MP0010307_abnormal_tumor_latency | 0.86488931 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.84614756 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.82370302 |
| 119 | MP0002210_abnormal_sex_determination | 0.82027083 |
| 120 | MP0009763_increased_sensitivity_to | 0.81838382 |
| 121 | MP0000371_diluted_coat_color | 0.81238401 |
| 122 | MP0000343_altered_response_to | 0.81100827 |
| 123 | MP0000249_abnormal_blood_vessel | 0.80658139 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.79531292 |
| 125 | MP0001542_abnormal_bone_strength | 0.79302820 |
| 126 | MP0003646_muscle_fatigue | 0.79111828 |
| 127 | MP0002429_abnormal_blood_cell | 0.78837906 |
| 128 | MP0001790_abnormal_immune_system | 0.78220654 |
| 129 | MP0005387_immune_system_phenotype | 0.78220654 |
| 130 | MP0003879_abnormal_hair_cell | 0.76048202 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.75780997 |
| 132 | MP0005257_abnormal_intraocular_pressure | 0.75074664 |
| 133 | MP0005384_cellular_phenotype | 0.74414542 |
| 134 | MP0009115_abnormal_fat_cell | 0.73414888 |
| 135 | MP0004130_abnormal_muscle_cell | 0.72298943 |
| 136 | MP0005023_abnormal_wound_healing | 0.72263311 |
| 137 | MP0005389_reproductive_system_phenotype | 0.71981988 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.71706489 |
| 139 | MP0001545_abnormal_hematopoietic_system | 0.71706489 |
| 140 | MP0002006_tumorigenesis | 0.71606113 |
| 141 | MP0002938_white_spotting | 0.71448386 |
| 142 | MP0000685_abnormal_immune_system | 0.70896477 |
| 143 | MP0000858_altered_metastatic_potential | 0.69337553 |
| 144 | MP0002796_impaired_skin_barrier | 0.68623906 |
| 145 | MP0003795_abnormal_bone_structure | 0.67312259 |
| 146 | MP0000026_abnormal_inner_ear | 0.66832389 |
| 147 | MP0002166_altered_tumor_susceptibility | 0.66021597 |
| 148 | MP0005171_absent_coat_pigmentation | 0.64661510 |
| 149 | MP0002405_respiratory_system_inflammati | 0.63974369 |
| 150 | MP0000703_abnormal_thymus_morphology | 0.63599371 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.63270226 |
| 152 | MP0005395_other_phenotype | 0.63101565 |
| 153 | MP0001186_pigmentation_phenotype | 0.63043835 |
| 154 | MP0004742_abnormal_vestibular_system | 0.62093239 |
| 155 | MP0003866_abnormal_defecation | 0.61743801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 5.29627523 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 5.18031443 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.58224774 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.51926705 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.97971807 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.68974223 |
| 7 | Abnormality of the axillary hair (HP:0100134) | 3.64848525 |
| 8 | Abnormality of secondary sexual hair (HP:0009888) | 3.64848525 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.52275729 |
| 10 | Abnormal protein glycosylation (HP:0012346) | 3.45081314 |
| 11 | Abnormal glycosylation (HP:0012345) | 3.45081314 |
| 12 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.45081314 |
| 13 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.45081314 |
| 14 | Prolonged bleeding time (HP:0003010) | 3.42895047 |
| 15 | Reticulocytopenia (HP:0001896) | 3.37188300 |
| 16 | Gingival bleeding (HP:0000225) | 3.32419119 |
| 17 | Chromsome breakage (HP:0040012) | 3.28566208 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.20802116 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 3.19770914 |
| 20 | Epistaxis (HP:0000421) | 3.13827092 |
| 21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.12018358 |
| 22 | Abnormal platelet volume (HP:0011876) | 3.06018359 |
| 23 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05226214 |
| 24 | Abnormality of the preputium (HP:0100587) | 3.04619561 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.03979556 |
| 26 | T lymphocytopenia (HP:0005403) | 3.03815846 |
| 27 | Recurrent skin infections (HP:0001581) | 3.03316020 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.01488335 |
| 29 | Orchitis (HP:0100796) | 3.00714971 |
| 30 | Myositis (HP:0100614) | 2.95580708 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95120264 |
| 32 | Obstructive lung disease (HP:0006536) | 2.95120264 |
| 33 | Myocardial infarction (HP:0001658) | 2.86365344 |
| 34 | Increased mean platelet volume (HP:0011877) | 2.85672830 |
| 35 | Optic neuritis (HP:0100653) | 2.84269206 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.84269206 |
| 37 | Recurrent viral infections (HP:0004429) | 2.82491966 |
| 38 | Meckel diverticulum (HP:0002245) | 2.78857453 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75534583 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.74263453 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.66375829 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66020728 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66020728 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66020728 |
| 45 | Breast hypoplasia (HP:0003187) | 2.64199997 |
| 46 | Gingivitis (HP:0000230) | 2.64178940 |
| 47 | Abnormality of the ileum (HP:0001549) | 2.61641380 |
| 48 | Macrocytic anemia (HP:0001972) | 2.60168440 |
| 49 | Stomatitis (HP:0010280) | 2.58990901 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58901487 |
| 51 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.58854494 |
| 52 | Subacute progressive viral hepatitis (HP:0006572) | 2.57853283 |
| 53 | Fatigue (HP:0012378) | 2.55647557 |
| 54 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.52939119 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.50975264 |
| 56 | Arterial thrombosis (HP:0004420) | 2.50258361 |
| 57 | Sex reversal (HP:0012245) | 2.49376158 |
| 58 | Abnormal sex determination (HP:0012244) | 2.49376158 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.49330266 |
| 60 | Menorrhagia (HP:0000132) | 2.46011996 |
| 61 | 3-Methylglutaconic aciduria (HP:0003535) | 2.44551424 |
| 62 | Cellulitis (HP:0100658) | 2.44250770 |
| 63 | Rough bone trabeculation (HP:0100670) | 2.42693269 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.40896123 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.40015995 |
| 66 | Abnormality of chromosome stability (HP:0003220) | 2.38339769 |
| 67 | Clubbing of toes (HP:0100760) | 2.36762041 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.35469754 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35469754 |
| 70 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.35005566 |
| 71 | Viral hepatitis (HP:0006562) | 2.34652710 |
| 72 | Thyroid-stimulating hormone excess (HP:0002925) | 2.33263607 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32540362 |
| 74 | Impulsivity (HP:0100710) | 2.32324570 |
| 75 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30023245 |
| 76 | Colitis (HP:0002583) | 2.29828197 |
| 77 | Exertional dyspnea (HP:0002875) | 2.28882948 |
| 78 | Increased hepatocellular lipid droplets (HP:0006565) | 2.27906442 |
| 79 | Vasculitis (HP:0002633) | 2.27315392 |
| 80 | Recurrent abscess formation (HP:0002722) | 2.25688475 |
| 81 | Birth length less than 3rd percentile (HP:0003561) | 2.25298819 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.25102247 |
| 83 | Capillary hemangiomas (HP:0005306) | 2.23392819 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23389320 |
| 85 | Urticaria (HP:0001025) | 2.23192729 |
| 86 | Papillary thyroid carcinoma (HP:0002895) | 2.22944933 |
| 87 | Prolonged neonatal jaundice (HP:0006579) | 2.21967385 |
| 88 | Cheilitis (HP:0100825) | 2.21931545 |
| 89 | Abnormal platelet function (HP:0011869) | 2.20974053 |
| 90 | Impaired platelet aggregation (HP:0003540) | 2.20974053 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 2.20082697 |
| 92 | Pallor (HP:0000980) | 2.19885310 |
| 93 | Osteomyelitis (HP:0002754) | 2.19659651 |
| 94 | Acute myeloid leukemia (HP:0004808) | 2.19588146 |
| 95 | Split foot (HP:0001839) | 2.19339114 |
| 96 | Chest pain (HP:0100749) | 2.18923547 |
| 97 | Bone marrow hypocellularity (HP:0005528) | 2.18227158 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.17008859 |
| 99 | Syringomyelia (HP:0003396) | 2.16461114 |
| 100 | Spinal cord lesions (HP:0100561) | 2.16461114 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.15946090 |
| 102 | Amyloidosis (HP:0011034) | 2.13601021 |
| 103 | Hypoplasia of the radius (HP:0002984) | 2.13019582 |
| 104 | Aplastic anemia (HP:0001915) | 2.11650362 |
| 105 | Triphalangeal thumb (HP:0001199) | 2.11281283 |
| 106 | Parakeratosis (HP:0001036) | 2.10611385 |
| 107 | Prostate neoplasm (HP:0100787) | 2.09615067 |
| 108 | Type 2 muscle fiber atrophy (HP:0003554) | 2.09483641 |
| 109 | Inflammation of the large intestine (HP:0002037) | 2.09307349 |
| 110 | Purpura (HP:0000979) | 2.09261602 |
| 111 | Duplicated collecting system (HP:0000081) | 2.08268232 |
| 112 | Entropion (HP:0000621) | 2.07152840 |
| 113 | Pancreatic fibrosis (HP:0100732) | 2.07089817 |
| 114 | Concave nail (HP:0001598) | 2.06693821 |
| 115 | Microvesicular hepatic steatosis (HP:0001414) | 2.06286877 |
| 116 | Abnormal trabecular bone morphology (HP:0100671) | 2.03698440 |
| 117 | Nonprogressive disorder (HP:0003680) | 2.03250907 |
| 118 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.03172751 |
| 119 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02703129 |
| 120 | Attenuation of retinal blood vessels (HP:0007843) | 2.00432425 |
| 121 | Abnormality of T cells (HP:0002843) | 2.00068710 |
| 122 | Leukocytosis (HP:0001974) | 1.98685436 |
| 123 | Abnormality of the columella (HP:0009929) | 1.98339916 |
| 124 | Periodontitis (HP:0000704) | 1.98233579 |
| 125 | Polycythemia (HP:0001901) | 1.98229241 |
| 126 | Petechiae (HP:0000967) | 1.98092616 |
| 127 | Pustule (HP:0200039) | 1.98049907 |
| 128 | Absent thumb (HP:0009777) | 1.97927843 |
| 129 | Encephalitis (HP:0002383) | 1.97890645 |
| 130 | Vacuolated lymphocytes (HP:0001922) | 1.97401012 |
| 131 | Amaurosis fugax (HP:0100576) | 1.96975787 |
| 132 | Abnormal spermatogenesis (HP:0008669) | 1.96454458 |
| 133 | Gastrointestinal inflammation (HP:0004386) | 1.96360090 |
| 134 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94485153 |
| 135 | Hypothermia (HP:0002045) | 1.94263394 |
| 136 | Muscle fiber atrophy (HP:0100295) | 1.92613380 |
| 137 | Increased IgE level (HP:0003212) | 1.92557960 |
| 138 | Anhidrosis (HP:0000970) | 1.91999720 |
| 139 | Abnormality of the renal collecting system (HP:0004742) | 1.91490386 |
| 140 | Sparse lateral eyebrow (HP:0005338) | 1.91005571 |
| 141 | Absent radius (HP:0003974) | 1.90847650 |
| 142 | Renal Fanconi syndrome (HP:0001994) | 1.90705044 |
| 143 | IgM deficiency (HP:0002850) | 1.90314057 |
| 144 | Progressive muscle weakness (HP:0003323) | 1.89559752 |
| 145 | Meningitis (HP:0001287) | 1.89207462 |
| 146 | Pancytopenia (HP:0001876) | 1.88442816 |
| 147 | Thrombocytosis (HP:0001894) | 1.87754759 |
| 148 | Abnormality of dental color (HP:0011073) | 1.87279683 |
| 149 | Loss of speech (HP:0002371) | 1.86547710 |
| 150 | Conjunctival telangiectasia (HP:0000524) | 1.85899460 |
| 151 | Abnormality of magnesium homeostasis (HP:0004921) | 1.85051358 |
| 152 | Deep philtrum (HP:0002002) | 1.84770209 |
| 153 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84471723 |
| 154 | Keratoconjunctivitis (HP:0001096) | 1.84110085 |
| 155 | Poikilocytosis (HP:0004447) | 1.83102955 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.83097383 |
| 157 | Absent forearm bone (HP:0003953) | 1.82975116 |
| 158 | Aplasia involving forearm bones (HP:0009822) | 1.82975116 |
| 159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82867936 |
| 160 | Mucopolysacchariduria (HP:0008155) | 1.82867936 |
| 161 | Abnormality of male internal genitalia (HP:0000022) | 1.82514232 |
| 162 | Small intestinal stenosis (HP:0012848) | 1.82154315 |
| 163 | Duodenal stenosis (HP:0100867) | 1.82154315 |
| 164 | Azoospermia (HP:0000027) | 1.81766590 |
| 165 | Mediastinal lymphadenopathy (HP:0100721) | 1.79358191 |
| 166 | Acute hepatic failure (HP:0006554) | 1.79170565 |
| 167 | Peritonitis (HP:0002586) | 1.78932540 |
| 168 | Dry hair (HP:0011359) | 1.78297919 |
| 169 | Pulmonary infiltrates (HP:0002113) | 1.77871934 |
| 170 | IgG deficiency (HP:0004315) | 1.77791770 |
| 171 | Ectopic kidney (HP:0000086) | 1.77313293 |
| 172 | Abnormality of DNA repair (HP:0003254) | 1.76932936 |
| 173 | Broad face (HP:0000283) | 1.75631982 |
| 174 | Coarse hair (HP:0002208) | 1.75540647 |
| 175 | Dysmetric saccades (HP:0000641) | 1.75422483 |
| 176 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.75322688 |
| 177 | Recurrent cutaneous fungal infections (HP:0011370) | 1.75322688 |
| 178 | Sparse eyelashes (HP:0000653) | 1.73937844 |
| 179 | Microcytic anemia (HP:0001935) | 1.73595902 |
| 180 | Micronodular cirrhosis (HP:0001413) | 1.73395662 |
| 181 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73385637 |
| 182 | Granulocytopenia (HP:0001913) | 1.73329121 |
| 183 | Severe visual impairment (HP:0001141) | 1.73308095 |
| 184 | True hermaphroditism (HP:0010459) | 1.73182903 |
| 185 | Abnormality of the common coagulation pathway (HP:0010990) | 1.72676885 |
| 186 | Hemoptysis (HP:0002105) | 1.72530272 |
| 187 | Premature graying of hair (HP:0002216) | 1.72124315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.10286755 |
| 2 | EIF2AK3 | 4.08479364 |
| 3 | STK16 | 3.71218770 |
| 4 | MKNK2 | 3.37054461 |
| 5 | CDK12 | 3.36167362 |
| 6 | CASK | 3.32063477 |
| 7 | BUB1 | 3.23866960 |
| 8 | NME2 | 3.21379807 |
| 9 | IRAK3 | 2.98681737 |
| 10 | WEE1 | 2.61772164 |
| 11 | MUSK | 2.47724093 |
| 12 | MAP2K3 | 2.41538633 |
| 13 | NLK | 2.40092617 |
| 14 | SRPK1 | 2.33653553 |
| 15 | MKNK1 | 2.24706938 |
| 16 | IRAK4 | 2.20924126 |
| 17 | CLK1 | 2.16744133 |
| 18 | AKT3 | 2.11106374 |
| 19 | EIF2AK2 | 2.06110631 |
| 20 | ERN1 | 1.95957438 |
| 21 | TLK1 | 1.95148006 |
| 22 | BLK | 1.89220584 |
| 23 | TYK2 | 1.73471450 |
| 24 | PIK3CG | 1.71820185 |
| 25 | PLK4 | 1.71210876 |
| 26 | CAMK1D | 1.68058078 |
| 27 | FES | 1.67964321 |
| 28 | ICK | 1.65789371 |
| 29 | WNK1 | 1.59247594 |
| 30 | NEK9 | 1.51522207 |
| 31 | PIM2 | 1.50818055 |
| 32 | JAK3 | 1.48035816 |
| 33 | ZAK | 1.46964052 |
| 34 | TAOK3 | 1.45603329 |
| 35 | CAMKK2 | 1.42493537 |
| 36 | VRK1 | 1.42024438 |
| 37 | TRPM7 | 1.41800466 |
| 38 | TEC | 1.41267904 |
| 39 | TXK | 1.40351832 |
| 40 | JAK1 | 1.36902961 |
| 41 | MAP3K1 | 1.33667696 |
| 42 | EIF2AK1 | 1.30262587 |
| 43 | YES1 | 1.24590706 |
| 44 | KSR2 | 1.23507329 |
| 45 | BRD4 | 1.21178900 |
| 46 | MAP3K2 | 1.20204158 |
| 47 | GRK6 | 1.20058843 |
| 48 | CDK6 | 1.19329253 |
| 49 | MAP3K3 | 1.16248584 |
| 50 | CAMK1G | 1.15998260 |
| 51 | JAK2 | 1.15947947 |
| 52 | SGK3 | 1.12156642 |
| 53 | STK10 | 1.10535178 |
| 54 | MAP3K13 | 1.07846628 |
| 55 | CSF1R | 1.07060990 |
| 56 | TBK1 | 1.03584516 |
| 57 | TRIB3 | 1.01228298 |
| 58 | DYRK3 | 1.00360053 |
| 59 | EPHB1 | 1.00017750 |
| 60 | SGK2 | 0.99869547 |
| 61 | TAOK1 | 0.99399304 |
| 62 | MARK2 | 0.98568885 |
| 63 | TAOK2 | 0.98274407 |
| 64 | CDK7 | 0.97857818 |
| 65 | IRAK2 | 0.97554995 |
| 66 | BRSK2 | 0.97392102 |
| 67 | IRAK1 | 0.97370488 |
| 68 | TTN | 0.97167753 |
| 69 | SMG1 | 0.96247477 |
| 70 | TSSK6 | 0.96217191 |
| 71 | CDK3 | 0.95021040 |
| 72 | RAF1 | 0.94865012 |
| 73 | EPHA2 | 0.91511833 |
| 74 | MAP3K6 | 0.91404101 |
| 75 | RIPK4 | 0.89749091 |
| 76 | IKBKB | 0.85921249 |
| 77 | ADRBK2 | 0.85160196 |
| 78 | MATK | 0.83355552 |
| 79 | MTOR | 0.82741008 |
| 80 | MAPK11 | 0.80321416 |
| 81 | PRKD2 | 0.79949318 |
| 82 | EEF2K | 0.78950463 |
| 83 | FGFR3 | 0.77410748 |
| 84 | PLK1 | 0.77045739 |
| 85 | ACVR1B | 0.77039530 |
| 86 | SCYL2 | 0.76421524 |
| 87 | GRK1 | 0.75954732 |
| 88 | TGFBR2 | 0.73859004 |
| 89 | KIT | 0.72563306 |
| 90 | CHUK | 0.70944110 |
| 91 | MAPK7 | 0.69887940 |
| 92 | PIM1 | 0.69798893 |
| 93 | CHEK2 | 0.68989779 |
| 94 | MAP4K1 | 0.68737359 |
| 95 | NEK2 | 0.67937434 |
| 96 | ITK | 0.67550095 |
| 97 | MELK | 0.66734316 |
| 98 | PDK1 | 0.65926312 |
| 99 | CSNK1G1 | 0.65415873 |
| 100 | TESK2 | 0.65230106 |
| 101 | PRPF4B | 0.63650383 |
| 102 | LYN | 0.62680334 |
| 103 | RET | 0.62286687 |
| 104 | GRK7 | 0.60058970 |
| 105 | HIPK2 | 0.60057539 |
| 106 | PDGFRB | 0.59143773 |
| 107 | ZAP70 | 0.59140994 |
| 108 | RPS6KA5 | 0.59099873 |
| 109 | PDPK1 | 0.58850151 |
| 110 | CAMK1 | 0.58227983 |
| 111 | CDC7 | 0.58026496 |
| 112 | STK38 | 0.57659149 |
| 113 | MAPK12 | 0.57111110 |
| 114 | FGFR4 | 0.54869688 |
| 115 | CDK4 | 0.54344574 |
| 116 | MARK3 | 0.54256025 |
| 117 | MAP2K7 | 0.54157137 |
| 118 | TTK | 0.53941453 |
| 119 | RPS6KL1 | 0.53494240 |
| 120 | RPS6KC1 | 0.53494240 |
| 121 | BTK | 0.52727899 |
| 122 | MST4 | 0.52243343 |
| 123 | MAP3K5 | 0.51919302 |
| 124 | IKBKE | 0.51619706 |
| 125 | MAP3K14 | 0.51571854 |
| 126 | AURKB | 0.51552396 |
| 127 | AURKA | 0.51484009 |
| 128 | MAP3K8 | 0.51023620 |
| 129 | CSK | 0.49259843 |
| 130 | PINK1 | 0.49013097 |
| 131 | FGR | 0.48416530 |
| 132 | SYK | 0.46461625 |
| 133 | KSR1 | 0.44671585 |
| 134 | BMPR2 | 0.44461671 |
| 135 | CDK8 | 0.42931546 |
| 136 | MAPK15 | 0.42325128 |
| 137 | LRRK2 | 0.42082907 |
| 138 | PTK2B | 0.42076885 |
| 139 | RPS6KA6 | 0.41948683 |
| 140 | CDK19 | 0.41559018 |
| 141 | CAMK4 | 0.41011086 |
| 142 | CSNK2A1 | 0.40780424 |
| 143 | PAK1 | 0.40753823 |
| 144 | BMPR1B | 0.40061269 |
| 145 | LCK | 0.37874726 |
| 146 | DYRK2 | 0.35916426 |
| 147 | CSNK2A2 | 0.35911367 |
| 148 | MAPK4 | 0.35570708 |
| 149 | ABL2 | 0.34123317 |
| 150 | NME1 | 0.33124880 |
| 151 | PLK3 | 0.32589785 |
| 152 | HCK | 0.32242955 |
| 153 | CSNK1G3 | 0.30406522 |
| 154 | PRKCI | 0.29253418 |
| 155 | PBK | 0.29012390 |
| 156 | ATR | 0.27425206 |
| 157 | BRAF | 0.25981427 |
| 158 | ABL1 | 0.25833457 |
| 159 | KDR | 0.25627664 |
| 160 | STK24 | 0.23867045 |
| 161 | MAP3K12 | 0.23291915 |
| 162 | NEK6 | 0.23003473 |
| 163 | CCNB1 | 0.22225450 |
| 164 | STK4 | 0.21507566 |
| 165 | STK3 | 0.21354473 |
| 166 | NUAK1 | 0.21148808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.56945064 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.38252680 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.20652021 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 2.94494573 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.84906008 |
| 6 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.64384449 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.58467619 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.35230096 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.28855825 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.25182078 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.23044993 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.08845634 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.08728456 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.07955987 |
| 15 | Basal transcription factors_Homo sapiens_hsa03022 | 2.03139105 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.00461955 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.86050720 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78034871 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.77970097 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.77040129 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72613678 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68241757 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.65516128 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.64845425 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59756284 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.58701941 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.58346339 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.58180778 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.54498954 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.53705299 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53306608 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.51818817 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50431333 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.50021889 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48668103 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.45215347 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42745322 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41775051 |
| 39 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.39292203 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35768634 |
| 41 | Cell cycle_Homo sapiens_hsa04110 | 1.35334478 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34638357 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.33226816 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29733701 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28829221 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26867125 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25023428 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21327243 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21311215 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20724392 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20566497 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20086441 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14239879 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12938754 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.12303071 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10508849 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10338410 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09800628 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 1.09482281 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 1.06981369 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06501027 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05670942 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02692875 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 1.01738542 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 1.01662016 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01164450 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00372385 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99671649 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.99573251 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99548869 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.99211949 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98699093 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98380667 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98220288 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97188832 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96808975 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.94485249 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93513138 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92092395 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88965339 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87833842 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86981572 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86591730 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86316802 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85755856 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85442381 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85325506 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84161693 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83798498 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83351232 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.82052164 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.80438330 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.79962390 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79679843 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.75656243 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74716433 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74090661 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73894798 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73769219 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73728996 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73523828 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72592759 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72424320 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72013525 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71520296 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71445069 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.69705274 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68819956 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67852683 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.67331221 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66676687 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66377719 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65998005 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65918834 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65520785 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64876342 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64864712 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.64598166 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63623750 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63575615 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62730974 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62107023 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62060096 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.57929547 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57837063 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56365133 |
| 127 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55595813 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54473642 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53892199 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53485580 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51860725 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51699680 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51604612 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51444946 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51269149 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50884925 |
| 137 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47467565 |
| 138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47097553 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40287394 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39882789 |
| 141 | Lysosome_Homo sapiens_hsa04142 | 0.39785930 |
| 142 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39616081 |
| 143 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37911768 |
| 144 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37673380 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36631105 |
| 146 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35684565 |
| 147 | Apoptosis_Homo sapiens_hsa04210 | 0.32112094 |
| 148 | Influenza A_Homo sapiens_hsa05164 | 0.31373749 |
| 149 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.31334487 |
| 150 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31331784 |
| 151 | Tuberculosis_Homo sapiens_hsa05152 | 0.30569018 |
| 152 | Nicotine addiction_Homo sapiens_hsa05033 | 0.29539312 |
| 153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29197829 |
| 154 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29062195 |
| 155 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28442331 |
| 156 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.26582118 |
| 157 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24763594 |
| 158 | Hepatitis B_Homo sapiens_hsa05161 | 0.24422553 |
| 159 | Pertussis_Homo sapiens_hsa05133 | 0.23523294 |
| 160 | Prostate cancer_Homo sapiens_hsa05215 | 0.23480217 |
| 161 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23296544 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | 0.22646553 |
| 163 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21382319 |
| 164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21235910 |

